RxSight (RXST) Equity Ratio (2020 - 2026)
RxSight posted quarterly Equity Ratio of 0.88 for Q1 2026, down 1.45% year-on-year from 0.89 in Q1 2025, and down 0.55% on a QoQ basis from 0.88 in Q4 2025.
RxSight (RXST) has 7 years of Equity Ratio data on file, last reported at 0.88 in Q1 2026.
- For the quarter ending Q1 2026, Equity Ratio fell 1.45% year-over-year to 0.88; the trailing twelve-month figure through Mar 2026 stood at 0.88 (down 1.45% YoY), and the FY2025 full-year result was 0.88, changed 0.15% from the prior year.
- Equity Ratio for Q1 2026 stood at 0.88, down from 0.88 in the prior quarter.
- Across five years, Equity Ratio topped out at 0.9 in Q2 2024 and bottomed at 0.6 in Q4 2022.
- The 5-year median for Equity Ratio is 0.88 (2024), against an average of 0.82.
- Peak annual rise in Equity Ratio reached 119.97% in 2022, while the deepest fall reached 16.79% in 2022.
- A 5-year view of Equity Ratio shows it stood at 0.6 in 2022, then jumped by 46.73% to 0.88 in 2023, then increased by 0.5% to 0.88 in 2024, then gained by 0.15% to 0.88 in 2025, then slipped by 0.55% to 0.88 in 2026.
- The last three Equity Ratio figures came in at 0.88 (Q1 2026), 0.88 (Q4 2025), and 0.89 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 0.47 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 0.50 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 0.54 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 0.59 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 0.78 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 0.45 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 0.29 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 0.67 |
| 10 | RxSight | 215.82 Mn | -2.06 Mn | 23.50 Mn | 0.88 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.88 |
| Dec 31, 2025 | 0.88 |
| Sep 30, 2025 | 0.89 |
| Jun 30, 2025 | 0.90 |
| Mar 31, 2025 | 0.89 |
| Dec 31, 2024 | 0.88 |
| Sep 30, 2024 | 0.89 |
| Jun 30, 2024 | 0.90 |
| Mar 31, 2024 | 0.89 |
| Dec 31, 2023 | 0.88 |
| Sep 30, 2023 | 0.89 |
| Jun 30, 2023 | 0.81 |
| Mar 31, 2023 | 0.72 |
| Dec 31, 2022 | 0.60 |
| Sep 30, 2022 | 0.62 |
| Jun 30, 2022 | 0.66 |
| Mar 31, 2022 | 0.70 |
| Dec 31, 2021 | 0.72 |
| Sep 30, 2021 | 0.74 |
| Jun 30, 2021 | -3.30 |
| Dec 31, 2020 | -4.28 |